Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-C2-acid is a compound designed by synthesizing an E3 ligase ligand-linker conjugate. It comprises a cereblon ligand derived from Thalidomide and a linker commonly used in PROTAC technology.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 35 days | $ 490.00 |
Description | Thalidomide-O-C2-acid is a compound designed by synthesizing an E3 ligase ligand-linker conjugate. It comprises a cereblon ligand derived from Thalidomide and a linker commonly used in PROTAC technology. |
In vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
Synonyms | Thalidomide-O-C2-acid |
Molecular Weight | 346.2916 |
Formula | C16H14N2O7 |
CAS No. | 2369068-42-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-C2-acid 2369068-42-6 Thalidomide O C2 acid Thalidomide-O-C-2-acid ThalidomideOC2acid inhibitor inhibit